海外の治験の状況「1」での検索結果
7748件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines
- Diffuse Intrinsic Pontine Glioma;Diffuse Intrinsic Pontine Glioma;Diffuse Intrinsic Pontine Glioma
- Spain
- 2016-05-31
Not Recruiting
- Oral vinorelbine as second-line therapy for patients with malignant pleural mesothelioma
- Specialty: Cancer, Primary sub-specialty: Lung Cancer; UKCRC code/ Disease: Cancer/ Malignant neoplasms of respiratory and intrathoracic organs Cancer Malignant pleural mesothelioma (MPM)
- United Kingdom
- 2017-01-23
Not recruiting
- Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma
- Cholangiocarcinoma Non-resectable;Non-metastatic;Cholangiocarcinoma Non-resectable;Non-metastatic;Cholangiocarcinoma Non-resectable;Non-metastatic;Cholangiocarcinoma Non-resectable;Non-metastatic
- France
- 2017-11-30
Not recruiting
- Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Ovarian Cancer;Ovarian Cancer;Ovarian Cancer
- Italy
- 2018-01-19
Not recruiting
- Patients With Relapsed Ovarian Cancer (2nd and 3rd Line) Treated With Chemotherapy According to AGO Guidelines
- Ovarian Cancer
- Germany
- 2018-01-18
Not recruiting
- An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck
- Head and Neck Cancer;Head and Neck Cancer;Head and Neck Cancer
- Argentina, Australia, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Germany, Italy, Japan, Korea, Republic of, Mexico, Poland, Romania, Russian Federation, Switzerland, Taiwan, Turkey, United Kingdom, United States
- 2017-12-22
Not recruiting
- First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)
- Esophageal Neoplasms
- Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Costa Rica, Denmark, France, Germany, Guatemala, Hong Kong, Japan, Korea, Republic of, Malaysia, Peru, Romania, Russian Federation, South Africa, Spain, Taiwan, Thailand, Turkey, United Kingdom, United States
- 2017-06-14
Not Recruiting
- A DOUBLE-BLIND, RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDY TO COMPARE EFFICACY AND SAFETY OF CT-P16 AND EU-APPROVED AVASTIN AS FIRST-LINE TREATMENT FOR METASTATIC OR RECURRENT NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
- -C34 Malignant neoplasm of bronchus and lung Malignant neoplasm of bronchus and lung;Malignant neoplasm of bronchus and lung
- Belarus, Brazil, Bulgaria, Chile, Croatia, Georgia, Hungary, India, Japan, Korea South, Malasya, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Thailand, Ukraine, Vietnam
- 2018-12-31
Not recruiting
- Study to Explore Morbimortality in Patients Dialyzed With the Theranova HDx in Comparison to On-Line-Hemodiafiltration
- Chronic Kidney Disease Requiring Chronic Dialysis
- Spain
- 2018-09-28
Not recruiting
- Continuous Wireless Monitoring in Internal Medicine Unit: the Green Line From Hospital to Territory
- Patient Monitoring
- Italy
- 2018-08-28
Not Recruiting
- Narrative Experiences ON-line (NEON): impact of recorded mental health recovery stories on quality of life in people experiencing psychosis
- Mental health Mental and Behavioural Disorders
- United Kingdom
- 2018-08-13
Not recruiting
- The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-a Status in Patients With Metastatic Breast Cancer HER2 + and ERa Neg Treated With Trastuzumab + Pertuzumab + Taxane.
- HER2-positive Breast Cancer
- France
- 2018-08-01
Not recruiting
- Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT)
- Non-small-cell Lung Cancer Patients
- Italy
- 2019-03-04
Not recruiting
- Atezolizumab Plus Bevacizumab in First Line NSCLC Patients
- Non Small Cell Lung Cancer
- Spain
- 2019-02-07
Not recruiting
- M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)
- Biliary Tract Cancer;Cholangiocarcinoma;Gallbladder Cancer
- Germany, United States
- 2019-02-06
Not recruiting
- Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment
- Non Small Cell Lung Cancer
- France
- 2019-02-05
Not recruiting
- Quality of Life in Elderly Patients With Metastatic Colorectal Cancer Receiving First-line Therapy Based on Simplified Geriatric Parameters
- Elderly Patients;Metastatic Colorectal Cancer;Quality of Life
- France
- 2019-01-29
Not recruiting
- Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)
- Non-Small Cell Lung Cancer
- Japan, Korea, Republic of, Norway, Spain, Sweden, United States
- 2019-04-29
Not recruiting
- MEtatastic Renal Carcinoma LINes
- Renal Cell Carcinoma
- France
- 2019-04-24
Not recruiting
- Folfirinox + Cetuximab Chemotherapy, in First Line, With Wild RAS and According to BRAF Status in Metastatic Colorectal Cancer
- Colorectal Cancer
- France
- 2019-04-11